Comparison of cardiac injury caused by persistent pulmonary hypertension and congenital heart disease-related pulmonary hypertension in the newborn
-
摘要: 目的:探讨新生儿持续性肺动脉高压(PPHN)与先天性心脏病相关肺动脉高压(PAH-CHD)在导致患儿心脏损伤方面的差异。方法:回顾性分析我院新生儿病房2014年11月—2020年6月收治的符合肺动脉高压的患儿161例,分为PPHN组与PAH-CHD组。比较两组患儿心脏超声指标与心肌酶的差异。结果:PAH-CHD组与PPHN组左房内径(LA)、左室内径(LV)及左室射血分数(LVEF)的差异具有统计学意义(P<0.05);其他指标如右房内径(RA)、右室内径(RV)及心肌酶在两组之间差异无统计学意义。结论:对比PPHN患儿,PAH-CHD更容易引起LV、LA及LVEF改变,临床需要尽早识别,进行干预。Abstract: Objective: To investigate the difference of cardiac injury between persistent pulmonary hypertension(PPHN) and congenital heart disease-related pulmonary hypertension(PAH-CHD) in neonatus.Methods: A total of 161 children with pulmonary hypertension in neonatal intensive care unit of our hospital from November 2014 to June 2020 were retrospectively included and divided into PPHN group and PAH-CHD group. The differences of echocardiography indicators and myocardial enzyme levels between the two groups were compared.Results: There were significant differences in left atrial diameter(LA), left ventricular diameter(LV), and left ventricular ejection fraction(LVEF) between PAH-CHD group and PPHN group(all P<0.05). There was no significant difference in other indexes such as right atrial diameter(RA), right ventricular diameter(RV), and myocardial enzymes between the two groups.Conclusion: Compared with PPHN, PAH-CHD is more likely to cause changes in cardiac structure and ejection fraction. In order to intervene, early identification is particularly necessary in clinic.
-
Key words:
- neonatus /
- pulmonary hypertension /
- congenital heart disease
-
[1] FuloriaM,Aschner JL.Persistent pulmonary hypertension of the newborn[J].Semin Fetal Neonatal Med,2017,4(22):220-226.
[2] Hilgendorff A,Apitz C,Bonnet D,et al.Pulmonary hypertension associated with acute or chronic lung diseases in the preterm and term neonate and infant.The European Paediatric Pulmonary Vascular Disease Network,endorsed by ISHLT and DGPK[J].Heart,2016,102 Suppl 2:i49-56.
[3] 许文婧,魏莉莉,王莹,等.我国围生儿先天性心脏病发病率的Meta分析[J].国际生殖健康/计划生育杂志,2020,39(4):269-275.
[4] 中华医学会儿科学分会新生儿学组,编辑委员会中华儿科杂志.新生儿肺动脉高压诊治专家共识[J].中华儿科杂志,2017,55(3):163-168.
[5] 高伟,顾红,胡大一,等.2015年先天性心脏病相关性肺动脉高压诊治中国专家共识[J].中国介入心脏病学杂志,2015,23(2):61-69.
[6] Steurer MA,Baer RJ,Oltman S,et al.Morbidity of persistent pulmonary hypertension of the newborn in the firstyear of life[J].J Pediatr,2019,213:58-65.
[7] 孟红,逄坤静,王浩,等.新生儿危重先天性心脏病的超声心动图诊断及外科治疗经验[J].中国循环杂志,2018,33(8):801-805.
[8] De B,Yogen S,Zoltan M,et al.Application of neonatologist performed echocardiography in the assessment and management of persistent pulmonary hypertension of the newborn[J].Pediatr Res,2018,84(S1):68-77.
[9] 张梦华,杨海娟,梁中信.新生儿持续肺动脉高压超声心动图表现与血清BNP,hs-cTnT的相关性[J].医学影像学杂志,2020,30(4):178-181.
[10] 徐茁原,张红胜,张陈,等.儿童先天性心脏病术后肺动脉高压与特发性肺动脉高压的临床特点及预后[J].心肺血管病杂志,2019,38(9):923-927.
[11] 吴群,马宁,李培,等.超声心动图在新生儿持续性肺动脉高压诊疗评价中的应用[J].中国循环杂志,2021,35(12):1207-1211.
[12] Nair J,Lakshminrusimha S.Update on PPHN:Mechanisms and treatment[J].Semin Perinatol,2014,38(2):78-91.
[13] 徐茁原,李强强,张陈,等.先天性心脏病相关肺动脉高压患者死亡的危险因素及不同亚型的临床特点[J].中华心血管病杂志,2020,48(4):315-322.
[14] 卢一品,刘宏生.肺动脉高压的发病机制和药物治疗进展[J].临床心血管病杂志,2019,35(2):109-112.
计量
- 文章访问数: 580
- PDF下载数: 336
- 施引文献: 0